ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
ChromaDex Corporation

ChromaDex Corporation (CDXC)

6,38
-0,07
(-1,09%)
Geschlossen 13 Dezember 10:00PM
6,57
0,19
( 2,98% )
Vor Marktöffnung: 2:17PM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
6,57
Gebot
6,25
Fragen
6,38
Volumen
623
0,00 Tagesbereich 0,00
1,32 52-Wochen-Bereich 7,9738
Marktkapitalisierung
Handelsende
6,38
Handelsbeginn
-
Letzter Handelszeitpunkt
14:15:12
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
1.296.211
Ausgegebene Aktien
76.383.267
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-98,76
Gewinn pro Aktie (EPS)
-0,06
Erlöse
83,57M
Nettogewinn
-4,94M

Über ChromaDex Corporation

ChromaDex Corp is a bioscience company dedicated to healthy aging. The ChromaDex team is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship in... ChromaDex Corp is a bioscience company dedicated to healthy aging. The ChromaDex team is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex's patent portfolio. It delivers Niagen as the sole active ingredient in its consumer product namely, Tru Niagen which is available on Tru Niagen's website and through partnerships with retailers and distributors. Mehr anzeigen

Sektor
Medicinal Chems,botanicl Pds
Branche
Medicinal Chems,botanicl Pds
Hauptsitz
Dover, Delaware, USA
Gegründet
-
ChromaDex Corporation is listed in the Medicinal Chems,botanicl Pds sector of the NASDAQ with ticker CDXC. The last closing price for ChromaDex was US$6,38. Over the last year, ChromaDex shares have traded in a share price range of US$ 1,32 to US$ 7,9738.

ChromaDex currently has 76.383.267 shares in issue. The market capitalisation of ChromaDex is US$487,33 million. ChromaDex has a price to earnings ratio (PE ratio) of -98.76.

CDXC Neueste Nachrichten

ChromaDex Named to the Inc. 2024 Best in Business List in the Health Products Category

ChromaDex Corp. (NASDAQ:CDXC) proudly announces its inclusion on the Inc. 2024 Best in Business list in the Health Products category. Inc.’s annual Best in Business Awards celebrate the...

ChromaDex’s Patented Nicotinamide Riboside (NR) Ingredient, Niagen®, Featured as the Hero Ingredient in Longevity.Technology’s Inaugural Longevity Supplement

The gold standard in NAD+ supplementation, Niagen® is a key ingredient for supporting cellular health and promoting healthy aging in Longevity.Technology’s new supplement ChromaDex Corp. (NASDAQ:...

ChromaDex's Pharmaceutical-Grade Niagen® IV Now Accessible at over 200 Restore Hyper Wellness Clinics Nationwide

National rollout provides enhanced accessibility to Niagen IV, a significant advancement in NAD+ IV therapy ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine...

ChromaDex Corporation Reports Third Quarter 2024 Financial Results

Total net sales of $25.6 million, up $6.1 million or 31% year-over-year, gross margin of 63.5% and record net income and adjusted EBITDA of $1.9 million and $2.9 million, respectively, for the...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.48-6.80851063837.057.056.345535396.58084452CS
4-0.46-6.543385490757.037.97386.348257967.23730425CS
122.8576.61290322583.727.97383.1812962116.04695681CS
263.41107.9113924053.167.97382.3057646305.44285996CS
525.2379.5620437961.377.97381.325059714.86924856CS
1562.19504.387.97381.153425823.43395519CS
2602.6165.90909090913.9623.661.155421128.14875682CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
TRUGTruGolf Holdings Inc
US$ 0,8212
(58,26%)
37,15M
LOOPLoop Industries Inc
US$ 1,70
(38,21%)
30,55M
AVLDirexion Daily AVGO Bull 2X Shares
US$ 30,50
(34,90%)
58k
AVGXDefiance Daily Target 2X Long AVGO ETF
US$ 28,80
(34,14%)
354,2k
WAVSWestern Acquisition Ventures Corporation
US$ 13,95
(28,03%)
342
RPTXRepare Therapeutics Inc
US$ 2,42
(-39,04%)
362,03k
CADLCandel Therapeutics Inc
US$ 6,50
(-33,67%)
3,02M
INOInovio Pharmaceuticals Inc New
US$ 2,51
(-33,24%)
369,85k
XXII22nd Century Group Inc
US$ 0,0514
(-30,07%)
3,3M
MDCXMedicus Pharma Ltd
US$ 2,00
(-27,27%)
3
TRUGTruGolf Holdings Inc
US$ 0,8178
(57,60%)
37,2M
LOOPLoop Industries Inc
US$ 1,70
(38,21%)
30,56M
VCIGVCI Global Ltd
US$ 1,99
(23,60%)
26,83M
SPISPI Energy Company Ltd
US$ 0,4439
(26,83%)
22,18M
LICNLichen China Limited
US$ 0,2166
(10,57%)
16,79M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock